{
    "Trade/Device Name(s)": [
        "Superbio Fentanyl Urine Detection Kit",
        "Superbio Immunofluorescence Analyzer EASY-11"
    ],
    "Submitter Information": "Shenzhen Superbio Technology Co., Ltd.",
    "510(k) Number": "K220046",
    "Predicate Device Reference 510(k) Number(s)": [
        "K180427",
        "K973547"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "KHO"
    ],
    "Summary Letter Date": "December 13, 2022",
    "Summary Letter Received Date": "August 29, 2022",
    "Submission Date": "December 2, 2022",
    "Regulation Number(s)": [
        "21 CFR 862.3650",
        "21 CFR 862.2560"
    ],
    "Regulation Name(s)": [
        "Opiate Test System",
        "Fluorometer for clinical use"
    ],
    "Analyte Class(es)": [
        "toxicology",
        "chemistry"
    ],
    "Analyte(s)": [
        "Fentanyl"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Superbio Immunofluorescence Analyzer EASY-11"
    ],
    "Method(s)/Technology(ies)": [
        "Fluorescence immunoassay",
        "Lateral flow immunochromatography"
    ],
    "Methodologies": [
        "Competitive binding immunoassay",
        "Fluorescence microsphere-labeled antibody detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Analyzer",
        "Test",
        "Cassette"
    ],
    "Document Summary": "FDA 510(k) summary for Superbio Fentanyl Urine Detection Kit and Immunofluorescence Analyzer EASY-11 for qualitative detection of fentanyl in human urine",
    "Indications for Use Summary": "Qualitative detection of fentanyl in human urine at a cutoff concentration of 1.0 ng/mL using fluorescence immunoassay with Superbio Immunofluorescence Analyzer EASY-11; for prescription use only, provides preliminary results that require confirmatory testing by GC/MS or LC/MS",
    "fda_folder": "Toxicology"
}